Drucker's team is investigating this issue alongside studying whether the beneficial effects of GLP-1 is mediated through the brain in various mouse models of inflammation, including heart disease, atherosclerosis, and liver and kidney inflammation
This is totally normal and usually gets better
However, in a large study involving people with diabetes who had no comorbidities, GLP-1 RAs were not shown to increase the risk of developing pancreatitis at any time point up through 5 years of use.[ref][ref][ref][ref] The Cleveland Clinic now counsels that GLP-1 RA patients should be screened for pancreatitis risk factors, and a lower dose should be used to reduce the risk of pancreatitis.[ref] Related article : Pancreatitis and Genetic Risk Factors Gastroparesis: Case reports tie semaglutide to a risk of gastroparesis (very slow stomach emptying)
These medications slow down the transit of food from the stomach to the gut, making you feel full, Dr
doi: 10.1126/scitranslmed.aar7047
Treasure Island (FL): StatPearls Publishing